Last reviewed · How we verify
NCT03129841
Effects of Late Dinner Against Early Dinner on Weight Loss Healthy Obese Women
NA trial testing Early dinner+Diet in Obesity in 70 participants. Completed in 18 November 2017.
5 October 2017
Quick facts
| Lead sponsor | Novindiet Clinic |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | treatment |
| Enrollment | 70 |
| Start date | 1 June 2017 |
| Primary completion | 5 October 2017 |
| Estimated completion | 18 November 2017 |
| Sites | 1 location across Iran |
Drugs / interventions tested
- Early dinner+Diet
- Late dinner+Diet
Conditions studied
- Obesity — all drugs for Obesity →
- Overweight — all drugs for Overweight →
Sponsor
Novindiet Clinic
Who can join
Adults 18 to 45, female only, with Obesity or Overweight. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The aim of the present study is to test whether late eating dinner could affect the amount of weight loss in healthy obese women in a weight-loss program.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT03129841
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Obesity
Currently open trials in the same condition.
- NCT07403604 — Effect of Insulin Lowering on Lipogenesis · Phase 1 · recruiting
- NCT07509307 — AMAZE 6: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Knee · Phase 3 · recruiting
- NCT07272837 — Impact of Semaglutide (Ozempic/Wegovy®) on Heart and Muscle Mass · recruiting
- NCT07481630 — A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Knee Osteoart · Phase 3 · recruiting
- NCT07527195 — Understanding the Effect of CagriSema, Cagrilintide, and Semaglutide on Muscle Health (Role of Amylin Signature in Muscl · Phase 1 · recruiting
Other Novindiet Clinic trials
Trials by the same sponsor.
- NCT03120429 — Effects of Moderate Consumption of Lean Fish on Weight Loss · NA · completed
- NCT03171961 — Effectiveness of Online Visit Compared With In-person Clinic Visit on Weight Loss · NA · completed
- NCT03120260 — Comparing Effect of Short Sleep Duration on Weight Loss of Overweight and Obese Women Attending a Weight Loss Program · NA · completed
- NCT03171922 — Effects of Internet-based Diet Plus Online Dietary Coach Compared With in Person Clinic Visit Approach on Weight Loss · NA · completed
- NCT03171948 — Effects of a Limited Almond Consumption After a Weight Loss Plan on Weight Maintenance · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03129841 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Novindiet Clinic
- Last refreshed: 28 October 2019
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03129841.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing